Yan Zhou

Dr. Yan Zhou


Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2012 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
MKMary Jeanne Kreek
Mary Jeanne Kreek
OLOrna Levran
Orna Levran
BRBrian Reed
Brian Reed
SSStefan D. Schlussman
Stefan D. Schlussman
YZYan Zhou
Yan Zhou
EBEduardo R. Butelman
Eduardo R. Butelman
Addictive diseases, including addiction to heroin, prescription opioids, or cocaine, pose massive personal and public health costs. Addictions are chronic relapsing diseases of the brain caused by drug-induced direct effects and persisting neuroadaptations at the epigenetic, mRNA, neuropeptide, neurotransmitter, or protein levels. These neuroadaptations, which can be specific to drug type, and their resultant behaviors are modified by various internal and external environmental factors, including stress responsivity, addict mindset, and social setting. Specific gene variants, including variants encoding pharmacological target proteins or genes mediating neuroadaptations, also modify vulnerability at particular stages of addiction. Greater understanding of these interacting factors through laboratory-based and translational studies have the potential to optimize early interventions for the therapy of chronic addictive diseases and to reduce the burden of relapse. Here, we review the molecular neurobiology and genetics of opiate addiction, including heroin and prescription opioids, and cocaine addiction.

18 March 2003 in Synapse
Verified
Journal Article
Closed access
PDF file
VYVadim Yuferov
Vadim Yuferov
TKThomas Kroslak
Thomas Kroslak
KLK. Steven Laforge
K. Steven Laforge
YZYan Zhou
Yan Zhou
AHAnn Ho
Ann Ho
MKMary Jeanne Kreek
Mary Jeanne Kreek

1 October 2006 in Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
YZYan Zhou
Yan Zhou
JBJacob Bendor
Jacob Bendor
LHLauren Hofmann
Lauren Hofmann
MRMatthew Randesi
Matthew Randesi
AHAnn Ho
Ann Ho
MKMary Jeanne Kreek
Mary Jeanne Kreek
In this study, we investigated the effects of acute morphine administration, chronic intermittent escalating-dose morphine administration and spontaneous withdrawal from chronic morphine on mRNA levels of mu opioid receptor (MOP-r), and the opioid peptides pro-opiomelanocortin (POMC) and preprodynorphin (ppDyn) in several key brain regions of the rat, associated with drug reward and motivated behaviors: lateral hypothalamus (lat.hyp), nucleus accumbens (NAc) core, amygdala, and caudate–putamen (CPu). There was no effect on MOP-r mRNA levels in these brain regions 30 min after either a single injection of morphine (10 mg/kg, i.p.) or chronic intermittent escalating-dose morphine (from 7.5 mg/kg per day on day 1 up to 120 mg/kg per day on day 10). Activation of the stress-responsive hypothalamic–pituitary–adrenal axis by 12 h withdrawal from chronic morphine was confirmed; both POMC mRNA levels in the anterior pituitary and plasma adrenocorticotropic hormone levels were significantly elevated. Under this withdrawal-related stress condition, there was an increase in MOP-r mRNA levels in the lat.hyp, NAc core, and CPu. Recent studies have demonstrated a novel role for the lat.hyp orexin (or hypocretin) activation in both drug-related positive rewarding, and withdrawal effects. Around 50% of lat.hyp orexin neurons express MOP-r. Therefore, we also examined the levels of lat.hyp orexin mRNA, and found them increased in morphine withdrawal, whereas there was no change in levels of the lat.hyp ppDyn mRNA, a gene coexpressed with the lat.hyp orexin. Our results show that there is an increase in MOP-r gene expression in a region-specific manner during morphine withdrawal, and support the hypothesis that increased lat.hyp orexin activity plays a role in morphine-withdrawal-related behaviors.

1 May 1996 in Molecular Brain Research
Verified
Journal Article
Closed access
RSRudolph Spangler
Rudolph Spangler
AHAnn Ho
Ann Ho
YZYan Zhou
Yan Zhou
CMChristopher E. Maggos
Christopher E. Maggos
VYVadim Yuferov
Vadim Yuferov
MKMary Jeanne Kreek
Mary Jeanne Kreek

1 April 1993 in European Journal of Pharmacology
Verified
Journal Article
Closed access
YZYan Zhou
Yan Zhou
YSYu-Hua Sun
Yu-Hua Sun
ZZZhi-Wen Zhang
Zhi-Wen Zhang
JHJi-Shen Han
Ji-Shen Han

18 April 2007 in Neuropsychopharmacology
Verified
Journal Article
Closed access
PDF file
YZYan Zhou
Yan Zhou
FLFrancesco Leri
Francesco Leri
ECErin Cummins
Erin Cummins
MHMarisa Hoeschele
Marisa Hoeschele
MKMary Jeanne Kreek
Mary Jeanne Kreek